Medicine and Dentistry
Malignant Neoplasm
100%
Body Mass Index
90%
Cancer Risk
86%
Colorectal Cancer
84%
Neoplasm
66%
Rectum Cancer
57%
Meta-Analysis
51%
Obesity
48%
Cytoreductive Surgery
37%
Surgery
36%
Chemoradiotherapy
36%
Diseases
30%
Somatomedin C
30%
Hazard Ratio
29%
Overall Survival
28%
Diabetes
28%
Biological Marker
27%
Anal Cancer
26%
Endometrial Cancer
26%
Acromegaly
26%
Hyperthermic Intraperitoneal Chemotherapy
25%
Cohort Analysis
22%
Pseudomyxoma Peritonei
21%
Preoperative Chemotherapy
20%
Breast Cancer
17%
Minoxidil
16%
Colonoscopy
16%
Pleomorphic Adenoma
16%
Growth Hormone
16%
Radiation Therapy
16%
Pelvic Exenteration
16%
Maturity Onset Diabetes of the Young
15%
Proportional Hazards Model
15%
Colorectal Liver Metastasis
15%
Prevalence
15%
Adenoma
14%
Recurrent Disease
14%
Colorectal Tumor
14%
Prospective Study
13%
Intraperitoneal Chemotherapy
13%
Meta-Regression
12%
Observational Study
12%
Colon Cancer
12%
Protein Binding
12%
Patient Referral
12%
Somatomedin B
12%
Metastatic Carcinoma
12%
Carcinoembryonic Antigen
11%
Lymph Node
11%
Cohort Effect
11%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
83%
Colorectal Cancer
73%
Obesity
34%
Neoplasm
34%
Rectum Cancer
29%
Biological Marker
27%
Anus Cancer
26%
Chemotherapy
24%
Cohort Study
22%
Acromegaly
20%
Disease
19%
Breast Cancer
17%
Somatomedin C
17%
Squamous Cell Carcinoma
15%
Colon Cancer
15%
Overall Survival
14%
Binding Protein
13%
Somatomedin B
12%
Prevalence
11%
Recurrent Disease
11%
Prostate Cancer
11%
Somatomedin Binding Protein 2
11%
Observational Study
10%
Somatomedin
10%
Peritoneum Metastasis
10%
Cancer Incidence
9%
Endometrium Cancer
9%
Cancer Mortality
9%
Cardiovascular Disease
8%
Cytokeratin 18
8%
Pharmacodynamics
8%
Carcinoembryonic Antigen
7%
Growth Hormone
7%
Intraperitoneal Chemotherapy
7%
Prospective Study
7%
Adenoma
7%
Sex Hormone
7%
Colorectal Carcinoma
6%
Case-Control Study
6%
Replacement Therapy
6%
Randomized Clinical Trial
6%
Carcinogenesis
6%
Progression Free Survival
6%
All Cause Mortality
6%
Insulin Analog
6%
Non Insulin Dependent Diabetes Mellitus
5%
Atherosclerosis
5%
Enzyme-Linked Immunosorbent Assay
5%
Parotid Gland Cancer
5%
Cediranib
5%